AKT1 and dermatitis: In contrast, in models of sulfur mustard induced dermatitis, the beneficial effects of the PARP inhibitor ABT-88, as well as the beneficial effects of PARP1 deficiency, appears to involve a significant modulation of the Akt pathway.